APA (7th ed.) Citation

Xu, Q., Chen, W., Cao, S., Li, X., Wu, X., & Ma, X. (2026). KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma. Scientific Reports, 16(1), 1. https://doi.org/10.1038/s41598-026-39061-x

Chicago Style (17th ed.) Citation

Xu, Qingjiang, Weili Chen, Senming Cao, Xiubin Li, Xiang Wu, and Xin Ma. "KLHDC4 Serves as a Novel Prognostic Biomarker and Drives Tumor Progression via PI3K/AKT Signaling in Clear Cell Renal Cell Carcinoma." Scientific Reports 16, no. 1 (2026): 1. https://doi.org/10.1038/s41598-026-39061-x.

MLA (9th ed.) Citation

Xu, Qingjiang, et al. "KLHDC4 Serves as a Novel Prognostic Biomarker and Drives Tumor Progression via PI3K/AKT Signaling in Clear Cell Renal Cell Carcinoma." Scientific Reports, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1038/s41598-026-39061-x.